Publication	Data		Fish	Anatomy
Rissone et al., 2019	Fig. 1.		ak2hg16/hg16 ,   ak2hg14/hg14 ,   ak2hg14/hg14; s356tTg	auditory receptor cell decreased amount, abnormal hair cell anterior macula decreased amount, abnormal whole organism dead, abnormal whole organism decreased life span, abnormal
	Fig. 2.		ak2hg14/hg14	posterior lateral line neuromast hair cell decreased amount, abnormal
	Fig. 3.		ak2hg14/hg14 ,   ak2hg14/hg14; s356tTg	posterior lateral line neuromast atoh1a expression decreased amount, abnormal posterior lateral line neuromast eya1 expression decreased amount, abnormal posterior lateral line neuromast GFP expression absent, abnormal
	Fig. 4.		ak2hg14/hg14; sqet20Et ,   ak2hg15/hg15; zf106Tg	posterior lateral line neuromast EGFP expression absent, abnormal posterior lateral line neuromast EGFP expression decreased amount, abnormal
	Fig. 5.		ak2hg14/hg14	posterior lateral line neuromast decreased amount, abnormal
	Fig. 6.		ak2hg15/hg15; s356tTg ,   ak2hg15/hg15; zf106Tg	posterior lateral line neuromast apoptotic process increased occurrence, abnormal
	Fig. 7.		ak2hg16/hg16 ,   ak2hg14/hg14	caudal hematopoietic tissue prdx2 expression decreased amount, abnormal otic vesicle gpx4a expression decreased amount, abnormal otic vesicle gpx4b expression decreased amount, abnormal otic vesicle prdx1 expression increased amount, abnormal otic vesicle prdx3 expression increased amount, abnormal otic vesicle prdx4 expression increased amount, abnormal otic vesicle prdx5 expression increased amount, abnormal otic vesicle prdx6 expression increased amount, abnormal posterior lateral line prdx1 expression increased amount, abnormal posterior lateral line neuromast gstp1.2 expression decreased amount, abnormal posterior lateral line neuromast prdx2 expression decreased amount, abnormal
	Fig. 8.		ak2hg14/hg14; s356tTg	auditory receptor cell decreased amount, abnormal hair cell anterior macula decreased amount, abnormal
Rissone et al., 2015	Fig. 2		ak2hg16/hg16 ,   ak2hg14/hg14	granulocyte decreased amount, abnormal lymphocyte differentiation decreased process quality, abnormal myeloid cell development decreased process quality, abnormal
	Fig. 3		EKW + MO1-ak2 + MO2-ak2 ,   EKW + MO2-ak2 ,   EKW + MO1-ak2	granulocyte decreased amount, abnormal lymphocyte differentiation decreased process quality, abnormal myeloid cell development decreased process quality, abnormal myeloid leukocyte differentiation decreased process quality, abnormal
	Fig. 4		EKW + MO1-ak2 + MO2-ak2 ,   EKW + MO2-ak2 ,   EKW + MO1-ak2 ,   ak2hg16/hg16 ,   la2Tg + MO1-ak2 + MO2-ak2 ,   ak2hg14/hg14 ,   la2Tg + MO2-ak2 ,   la2Tg + MO1-ak2	hematopoietic progenitor cell differentiation decreased process quality, abnormal hematopoietic stem cell differentiation decreased process quality, abnormal
	Fig. 5		EKW + MO1-ak2 + MO2-ak2 ,   EKW + MO2-ak2 ,   EKW + MO1-ak2 ,   ak2hg16/hg16 ,   ak2hg14/hg14	blood island apoptotic process increased process quality, abnormal hematopoietic system apoptotic process increased process quality, abnormal intermediate cell mass of mesoderm apoptotic process increased process quality, abnormal
Pannicke et al., 2009	Fig. 3		WT + MO1-ak2	leukocyte differentiation disrupted, abnormal
	Fig. S4		WT + MO1-ak2	leukocyte differentiation disrupted, abnormal